Health Systems Prioritize Revenue and Workforce Transformation Amid AI Integration
An analysis of global health system priorities, focusing on revenue growth, workforce challenges, and the nascent integration of Artificial Intelligence in healthcare operations.
The global healthcare sector is navigating a period of significant strategic realignment, driven by pressures related to revenue generation and workforce management. According to data from Deloitte Global’s 2026 Health Care Outlook Survey, health system executives across key markets are generally optimistic about their operational trajectories, though regional nuances persist. Over 80% of executives surveyed in nations including Australia, Canada, Germany, the Netherlands, and the United Kingdom reported a positive or cautiously positive outlook for their respective organizations, with only a negligible percentage expressing a negative view.
These strategic priorities are heavily influenced by the need for operational efficiency and sustainable revenue streams. A substantial majority of executives anticipate operating revenue and margins to increase in the coming year, while operating costs are projected to remain flat or decline slightly. To realize these gains, the focus is shifting towards leveraging core business technologies, expanding digital and Artificial Intelligence (AI) tools, and enhancing workforce engagement and retention strategies.
One of the most tangible areas of anticipated cost reduction lies in the application of AI for standardizing and automating complex workflows. Furthermore, predictive analytics is increasingly seen as a tool to optimize workforce deployment, with over half of respondents identifying potential savings in this area. The utilization of tech-enabled patient engagement platforms and remote monitoring solutions is also highlighted as a pathway to operational improvements.
Care model transformation is identified as a critical driver for revenue growth. This transformation is manifested through the expansion of outpatient services, the deepening of digital offerings, and the deployment of AI agents designed to manage patient follow-up. Beyond operational improvements, the integration of AI for risk stratification—evaluating health risks based on genetics, environmental factors, and lifestyle—is being explored as a method to facilitate more proactive and targeted patient interventions. This approach moves care from reactive treatment toward preventative, personalized strategies.
However, the integration of advanced technologies like generative AI is still in its nascent stages across the broader health system landscape. While generative AI is acknowledged as a potential force, the widespread, large-scale strategic impact expected in 2026 remains relatively limited. Current deployment is concentrated in select areas, with approximately 30% of surveyed health systems reported operating generative AI at scale within specific organizational domains, whereas only a minor fraction reported enterprise-wide adoption. This limited penetration underscores the early stage of adoption, particularly concerning clinical applications.
Industry intelligence suggests that the trajectory of health system investment will be dictated by the successful translation of digital and AI capabilities into measurable operational and clinical outcomes. The successful navigation of evolving regulatory landscapes, alongside securing the necessary workforce skills, will determine the speed and scale of these transformations. Future developments will likely see a continued maturation of AI from experimental tools to embedded operational infrastructure, contingent upon robust data governance frameworks and clear clinical validation pathways. The long-term outlook suggests a continuous evolution of care models, heavily reliant on data-driven insights to manage complexity and improve patient outcomes in an increasingly technologically mediated environment.